# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092163
Filing Date
2024-08-07
Accepted
2024-08-06 19:48:56
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-20240630.htm iXBRL | 10-Q | 1872743
2 | EX-10.9 | acad-ex10_9.htm | EX-10.9 | 37659
3 | EX-31.1 | acad-ex31_1.htm | EX-31.1 | 10657
4 | EX-31.2 | acad-ex31_2.htm | EX-31.2 | 10807
5 | EX-32.1 | acad-ex32_1.htm | EX-32.1 | 7526
6 | EX-32.2 | acad-ex32_2.htm | EX-32.2 | 7584
| Complete submission text file | 0000950170-24-092163.txt |  | 7705381

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acad-20240630.xsd | EX-101.SCH | 920575
66 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20240630_htm.xml | XML | 1464819

Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 241180997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)